Anagrelide 500microgram capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

anagrelide 500microgram capsules

mylan - anagrelide hydrochloride - capsule - 500microgram

Anagrelide 500microgram capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

anagrelide 500microgram capsules

dr reddy's laboratories (uk - anagrelide hydrochloride - capsule - 500microgram

Xagrid European Union - English - EMA (European Medicines Agency)

xagrid

shire pharmaceutical contracts limited - anagrelide - thrombocythemia, essential - antineoplastic agents - xagrid is indicated for the reduction of elevated platelet counts in at-risk essential-thrombocythaemia (et) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.

Anagrelid Sandoz 0.5 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

anagrelid sandoz 0.5 mg hard caps.

sandoz sa-nv - anagrelide hydrochloride 0,61 mg - eq. anagrelide 0,5 mg - capsule, hard - 0,5 mg - anagrelide hydrochloride 0.61 mg - anagrelide

Atremia 0.5 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atremia 0.5 mg hard caps.

teva b.v. - anagrelide hydrochloride monohydrate 0,61 mg - eq. anagrelide 0,5 mg - capsule, hard - 0,5 mg - anagrelide hydrochloride monohydrate 0.61 mg - anagrelide

AGRYLIN CAPSULE Canada - English - Health Canada

agrylin capsule

takeda canada inc - anagrelide (anagrelide hydrochloride) - capsule - 0.5mg - anagrelide (anagrelide hydrochloride) 0.5mg - platelet-reducing agents

ANAGRELIDE B&B anagrelide (as hydrochloride) 0.5 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

anagrelide b&b anagrelide (as hydrochloride) 0.5 mg capsule blister pack

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: povidone; magnesium stearate; lactose monohydrate; microcrystalline cellulose; lactose; crospovidone; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagrelide b&b capsules are indicated for the treatment of essential thrombocythaemia

ANAGRELIDE B&B anagrelide (as hydrochloride) 0.5 mg capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

anagrelide b&b anagrelide (as hydrochloride) 0.5 mg capsule bottle

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; povidone; lactose; magnesium stearate; lactose monohydrate; crospovidone; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagrelide b&b capsules are indicated for the treatment of essential thrombocythaemia.

Agrylin Australia - English - Department of Health (Therapeutic Goods Administration)

agrylin

shire australia pty ltd - anagrelide hydrochloride -

AGRYLIN CAPSULE 0.5 mg Singapore - English - HSA (Health Sciences Authority)

agrylin capsule 0.5 mg

takeda pharmaceuticals (asia pacific) pte. ltd. - anagrelide (as hcl) - capsule - 0.61mg - anagrelide (as hcl) 0.61mg